Selım Gürel

5.0k total citations · 1 hit paper
50 papers, 3.0k citations indexed

About

Selım Gürel is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Selım Gürel has authored 50 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 31 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Selım Gürel's work include Hepatitis B Virus Studies (30 papers), Hepatitis C virus research (30 papers) and Liver Disease Diagnosis and Treatment (24 papers). Selım Gürel is often cited by papers focused on Hepatitis B Virus Studies (30 papers), Hepatitis C virus research (30 papers) and Liver Disease Diagnosis and Treatment (24 papers). Selım Gürel collaborates with scholars based in Türkiye, Germany and France. Selım Gürel's co-authors include Cihan Yurdaydın, Patrick Marcellin, Teerha Piratvisuth, Ferruccio Bonino, Patrizia Farci, Rui Jin, George Lau, Stephanos J. Hadziyannis, Zhi‐Meng Lu and Georgios Germanidis and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Selım Gürel

47 papers receiving 2.9k citations

Hit Papers

Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Tw... 2004 2026 2011 2018 2004 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
    2004 847 citations Patrick Marcellin, George Lau et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Selım Gürel Türkiye 20 2.8k 2.8k 227 75 62 50 3.0k
G. Kitis Greece 17 2.5k 0.9× 2.4k 0.9× 364 1.6× 44 0.6× 130 2.1× 40 2.7k
Naoky Tsai United States 20 1.7k 0.6× 1.6k 0.6× 223 1.0× 51 0.7× 33 0.5× 55 1.8k
Chao‐Wei Hsu Taiwan 19 1.3k 0.5× 1.3k 0.5× 139 0.6× 45 0.6× 80 1.3× 72 1.6k
Hugo Cheinquer Brazil 19 2.0k 0.7× 2.1k 0.7× 197 0.9× 43 0.6× 65 1.0× 75 2.2k
Hillel Tobias United States 15 1.5k 0.5× 1.4k 0.5× 144 0.6× 39 0.5× 76 1.2× 22 1.7k
Ming‐Yuh Hsieh Taiwan 25 1.8k 0.6× 1.9k 0.7× 145 0.6× 92 1.2× 88 1.4× 72 2.2k
Pieter Honkoop Netherlands 18 1.7k 0.6× 1.6k 0.6× 512 2.3× 43 0.6× 236 3.8× 42 2.0k
F. Tremolada Italy 19 1.6k 0.6× 1.6k 0.6× 115 0.5× 70 0.9× 62 1.0× 43 1.8k
Andrew J. Muir United States 14 998 0.4× 1.2k 0.4× 218 1.0× 71 0.9× 56 0.9× 35 1.4k
Eduardo B. Martins United States 17 1.1k 0.4× 1.0k 0.4× 133 0.6× 114 1.5× 110 1.8× 42 1.4k

Countries citing papers authored by Selım Gürel

Since Specialization
Citations

This map shows the geographic impact of Selım Gürel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selım Gürel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selım Gürel more than expected).

Fields of papers citing papers by Selım Gürel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selım Gürel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selım Gürel. The network helps show where Selım Gürel may publish in the future.

Co-authorship network of co-authors of Selım Gürel

This figure shows the co-authorship network connecting the top 25 collaborators of Selım Gürel. A scholar is included among the top collaborators of Selım Gürel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selım Gürel. Selım Gürel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aksoy, Seçil Ak, Tuncay Yılmazlar, Ömer Yerci, et al.. (2023). Frequency and Clinical Impact of Microsatellite Instability in Colorectal Dysplasia Subgroups. Turkish Journal of Colorectal Disease. 33(2). 43–47.
2.
Kıyıcı, Murat, Macit Gülten, Enver Dolar, et al.. (2023). Importance of using tissue PCR to diagnose CMV colitis in ulcerative colitis. Dicle Medical Journal / Dicle Tip Dergisi. 50(2). 203–210.
3.
Wei, Lai, Heiner Wedemeyer, Yun‐Fan Liaw, et al.. (2018). No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B. PLoS ONE. 13(7). e0199198–e0199198. 7 indexed citations
4.
Kaymakoğlu, Sabahattin, İftihar Köksal, Fehmı Tabak, et al.. (2017). Recommendation for treatment of hepatitis C virus infection. The Turkish Journal of Gastroenterology. 28(2). 94–100. 2 indexed citations
5.
Buti, Marı́a, Scott Fung, Edward Gane, et al.. (2015). Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years. Hepatology International. 9(2). 243–250. 46 indexed citations
6.
Marcellin, Patrick, Marı́a Buti, Robert A. de Man, et al.. (2014). Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate. Journal of Hepatology. 61(6). 1228–1237. 80 indexed citations
7.
Buti, Marı́a, Naoky Tsai, Joerg Petersen, et al.. (2014). Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection. Digestive Diseases and Sciences. 60(5). 1457–1464. 206 indexed citations
8.
Gürel, Selım, et al.. (2013). Somatostatin Receptor 1 (SSTR1) and Somatostatin Receptor 5 (SSTR5) Expressions in Hepatocellular Carcinoma. Bursa Uludag University - AVESIS. 1 indexed citations
9.
Wedemeyer, Heiner, Yun‐Fan Liaw, Henry Lik-Yuen Chan, et al.. (2013). No association between IL28B genotype and response to peginterferon alfa-2a (40KD) in HBe antigen-positive and HBe antigen-negative patients with chronic hepatitis B in three large randomized clinical studies. Hepatology. 58. 1 indexed citations
10.
Fung, Scott, Peter Kwan, Milotka Fabri, et al.. (2013). Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B. Gastroenterology. 146(4). 980–988.e1. 114 indexed citations
11.
Bor, Serhat, Ülkü Dağlı, Selım Gürel, et al.. (2011). A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey. The Turkish Journal of Gastroenterology. 22(3). 249–254. 10 indexed citations
12.
Mederacke, Ingmar, Cihan Yurdaydın, Anika Großhennig, et al.. (2011). Renal function during treatment with adefovir plus peginterferon alfa‐2a vs either drug alone in hepatitis B/D co‐infection. Journal of Viral Hepatitis. 19(6). 387–395. 5 indexed citations
13.
Wedemeyer, Heiner, Cihan Yurdaydın, George Ν. Dalekos, et al.. (2011). Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta. New England Journal of Medicine. 364(4). 322–331. 313 indexed citations
14.
Ölmez, Ömer Fatih, Selım Gürel, & Yusuf Yılmaz. (2010). Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis. European Journal of Gastroenterology & Hepatology. 22(4). 461–465. 10 indexed citations
15.
Marcellin, Patrick, Ferruccio Bonino, George Lau, et al.. (2009). Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a. Gastroenterology. 136(7). 2169–2179.e4. 225 indexed citations
16.
Zachou, Kalliopi, Cihan Yurdaydın, Uta Drebber, et al.. (2009). Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver International. 30(3). 430–437. 82 indexed citations
17.
Bor, Serhat, Rukiye Vardar, Necati Örmecı, et al.. (2007). Prevalence patterns of gastric cancers in Turkey: Model of a developing country with high occurrence of Helicobacter pylori. Journal of Gastroenterology and Hepatology. 22(12). 2242–2245. 16 indexed citations
18.
Bulut, Mehtap, et al.. (2004). Acil servise epigastrik ağrı yakınmasıyla başvuran hastalarda helicobacter pylori sıklığı ve tanıda kalitatif serum Ig G testinin yeri. DergiPark (Istanbul University). 30(1). 7–10. 2 indexed citations
19.
Gürel, Selım, et al.. (2004). Varis ve Malignite Dışı Üst Gastrointestinal Sistem Kanamalarının Değerlendirilmesi. DergiPark (Istanbul University). 30(2). 87–91. 1 indexed citations
20.
Çakaloğlu, Yılmaz, Kadir Demır, Selim Badur, et al.. (1998). Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?. Journal of Hepatology. 28(1). 78–83. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Kitis Breakdown of academic impact, for papers by Naoky Tsai Breakdown of academic impact, for papers by Chao‐Wei Hsu Breakdown of academic impact, for papers by Hugo Cheinquer Breakdown of academic impact, for papers by Hillel Tobias Breakdown of academic impact, for papers by Ming‐Yuh Hsieh Breakdown of academic impact, for papers by Pieter Honkoop Breakdown of academic impact, for papers by F. Tremolada Breakdown of academic impact, for papers by Andrew J. Muir Breakdown of academic impact, for papers by Eduardo B. Martins
Rankless by CCL
2026